CD4 c.706_708delinsTGG ;(p.G236W)

Variant ID: 12-6925320-GGC-TGG

NM_000616.4(CD4):c.706_708delinsTGG;(p.G236W)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy.

Biotechnology And Bioprocess Engineering : Bbe
Kang, Seung Hyun SH; Lee, Chang-Han CH
Publication Date: 2021

Variant appearance in text: CD4: G236W
PubMed Link: 34220207
Variant Present in the following documents:
  • 12257_2020_Article_181.pdf
View BVdb publication page



Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Ha, Danbee D; Tanaka, Atsushi A; Kibayashi, Tatsuya T; Tanemura, Atsushi A; Sugiyama, Daisuke D; Wing, James Badger JB; Lim, Ee Lyn EL; Teng, Karen Wei Weng KWW; Adeegbe, Dennis D; Newell, Evan W EW; Katayama, Ichiro I; Nishikawa, Hiroyoshi H; Sakaguchi, Shimon S
Publication Date: 2019-01-08

Variant appearance in text: CD4: G236W
PubMed Link: 30587582
Variant Present in the following documents:
  • Main text
View BVdb publication page